ArriVent BioPharma
AVBP
#7246
Rank
A$0.82 B
Marketcap
A$15.89
Share price
-6.57%
Change (1 day)
-49.56%
Change (1 year)

ArriVent BioPharma (AVBP) - Total debt

Total debt on the balance sheet as of June 2026 : A$0.53 Million

According to ArriVent BioPharma's latest financial reports the company's total debt is A$0.53 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

ArriVent BioPharma - Total debt on balance sheet (from 2022 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$0.02 M-92.61%
2024-12-31A$0.28 M-39.19%
2023-12-31A$0.46 M127.79%
2022-12-31A$0.2 M
2021-12-31N/A